Skip to content

Evaluating Ureteral Length Using Computed Tomography (CT)

Evaluation of Ureteral Length Measurement by Computed Tomography (CT) to Actual Ureteral Length Measured by Ureteral Catheterization

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01542593
Acronym
URO-Y-2
Enrollment
53
Registered
2012-03-02
Start date
2012-02-29
Completion date
2015-03-31
Last updated
2015-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydronephrosis, Ureteral Calculi, Ureteral Obstruction

Brief summary

Proper selection of ureteral stent length might help in reducing comorbidities associated with ureteral stenting, currently there is no standardized way of measuring ureteral length. Measurement of ureteral length according to Computed Tomography (CT) scan might provide useful information when selecting the length of a ureteral stent. Our aim in this study is to compare ureteral measurements using CT scan and measurement of actual ureteral length measured during ureteral stenting.

Interventions

DEVICEUreteral catheterization - Cook Urological Inc. open end ureteral catheter 5FR

During a planned procedure involving ureteroscopy or ureteral stenting, after retrograde pyelography and insertion of a safety wire, ureteral catheterization will be performed using Cook Urological Inc. open end ureteral catheter 5FR for the purpose of measuring exact ureteral length. Measurement results will be compared to measurements performed on CT scan (obtained before surgery).

Sponsors

Carmel Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing planned procedure involving ureteroscopy or ureteral stenting * Abdominal CT scan performed within 6 months prior to intervention

Exclusion criteria

* Known iodine sensitivity * Patients with fever or hemodynamic instability planned for urgent operation * Severe immune compromized patients * Severe thrombocytopenia \< 50,000

Design outcomes

Primary

MeasureTime frame
Agreement between measurement of ureteral length (Centimeters) measured by CT and by ureteral catheterization1 year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026